Team-NB members adopted, at the unanimity of the presents, a paper prepared by the 30 members of the task force with the aim to provide an overview of the Team-NB perspective on the challenges of the AI Act with particular attention to its implementation.
News & Trends
Procurar
Recentes
- The first harmonised standard under the EU AI Act is here
- PHARMA PACKAGE : Council adopts new rules for a fairer and more competitive EU pharmaceutical sector
- HTA Regulation – Commission selects first medical devices for joint clinical assessment
- PHARMACOVIGILANCE UPDATE | FDA E2B(R3) IMPLEMENTATION GUIDE — OCTOBER 2026
- updated PIC/S PI 006-4 guideline RECOMMENDATIONS ON QUALIFICATION AND VALIDATION
- Annual report of the Pharmacovigilance Inspectors Working Group for 2025
- European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
- ACT EU workplan 2026 – 2027